Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gao, Ge ^a   Xuan, Chao ^b   Yang, Qin ^a,c   Liu, Xiao Cheng ^b   Liu, Zhi Gang ^b   He, Guo Wei ^a,d  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b TEDA INTERNATIONAL CARDIOVASCULAR HOSPITAL   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE I; COMPLEMENT COMPONENT C4A; TRANSFERRIN; VITRONECTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEOMICS; RHEUMATIC HEART DISEASE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VALVULAR HEART DISEASE;

BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

EID: 84883187007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072111     Document Type: Article

References (49)

1. Soler-Soler J, Galve E, (2000) Worldwide perspective of valve disease. Heart 83: 721-725.
2. Li ZX, Guo ZP, Liu XC, Kong XR, Jing WB, et al. (2012) Surgical treatment of tricuspid regurgitation after mitral valve surgery: a retrospective study in China. J Cardiothorac Surg 7: 30.
3. He GW, Acuff TE, Ryan WH, Douthit MB, Bowman RT, et al. (1994) Aortic valve replacement: determinants of operative mortality. Ann Thorac Surg 57: 1140-1146.
4. Maganti K, Rigolin VH, Sarano ME, Bonow RO, (2010) Valvular heart disease: diagnosis and management. Mayo Clin Proc 85: 483-500.
5. Carapetis JR, Steer AC, Mulholland EK, Weber M, (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685-694.
6. Hu SS, Kong LZ (2009) Report on Cardiovascular Diseases in China. Beijing: Encyclopedia of China Publishing House. 104 p.
7. Anderson NL, Anderson NG, (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
8. Zhao L, Liu Y, Sun X, Peng K, Ding Y, (2011) Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma. J Comp Pathol 144: 187-194.
9. Alastair Aitken (2005) Identification of Proteins by MALDI-TOF MS. In: Walker JM, editor. The Proteomics Protocols Handbook. New York: Human Press. pp.319-324.
10. Xuan C, Gao G, Bai XY, Liu XC, Yang Q, et al. (2012) Proteomic study reveals plasma protein changes in congenital heart diseases and potential clinical significance. Circulation 126: A15182.
11. Martin-Rojas T, Gil-Dones F, Lopez-Almodovar LF, Padial LR, Vivanco F, et al. (2012) Proteomic profile of human aortic stenosis: insights into the degenerative process. J Proteome Res 11: 1537-1550.
12. Gil-Dones F, Darde VM, Alonso-Orgaz S, Lopez-Almodovar LF, Mourino-Alvarez L, et al. (2012) Inside human aortic stenosis: a proteomic analysis of plasma. J Proteomics 75: 1639-1653.
13. Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-Caceres P, et al. (2010) Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation. J Cardiovasc Electrophysiol 21: 859-868.
14. Fae KC, Diefenbach dSD, Bilate AM, Tanaka AC, Pomerantzeff PM, et al. (2008) PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J Autoimmun 31: 136-141.
15. Matt P, Fu Z, Carrel T, Huso DL, Dirnhofer S, et al. (2007) Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J Mol Cell Cardiol 43: 792-801.
16. Marko-Varga G, Lindberg H, Lofdahl CG, Jonsson P, Hansson L, et al. (2005) Discovery of biomarker candidates within disease by protein profiling: principles and concepts. J Proteome Res 4: 1200-1212.
17. Chambers G, Lawrie L, Cash P, Murray GI, (2000) Proteomics: a new approach to the study of disease. J Pathol 192: 280-288.
18. Issaq H, Veenstra T, (2008) Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): advances and perspectives. Biotechniques 44: 697-8.
19. Wittmann-Liebold B, Graack HR, Pohl T, (2006) Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 6: 4688-4703.
20. Gozal D, Jortani S, Snow AB, Kheirandish-Gozal L, Bhattacharjee R, et al. (2009) Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 180: 1253-1261.
21. Tannu NS, Howell LL, Hemby SE, (2010) Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol Psychiatry 15: 185-203.
22. Ma Q, Geng Y, Xu W, Wu Y, He F, et al. (2010) The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. J Proteome Res 9: 40-49.
23. Li L, Sevinsky JR, Rowland MD, Bundy JL, Stephenson JL, et al. (2010) Proteomic analysis reveals virus-specific Hsp25 modulation in cardiac myocytes. J Proteome Res 9: 2460-2471.
24. Sly WS, Hu PY, (1995) Human carbonic anhydrases and carbonic anhydrase deficiencies. Ann Rev Biochem 64: 375-401.
25. Hewett-Emmett D, Tashian RE, (1996) Functional diversity, conservation, and convergence in the evolution of the alpha-, beta-, and gamma-carbonic anhydrase gene families. Mol Phylogenet Evol 5: 50-77.
26. Henry RP, (1996) Multiple roles of carbonic anhydrase in cellular transport and metabolism. Ann Rev Physiol 58: 523-538.
27. Carter ND, Dodgson SJ, Gross G, Tashian RE (1991) The Carbonic Anhydrases: Cellular Physiology and Molecular Genetics. New York: Plenum. 197-207 p.
28. Supuran CT, (2008) Carbonic anhydrases-an overview. Curr Pharm Des 14: 603-614.
29. Parissa M, Koorosh A, Nader M, (2007) Investigating the Application of Enzyme Carbonic Anhydrase for CO2 sequestration purposes. Ind Eng Chem Res 46: 921-926.
30. Ramanan R, Kannan K, Sivanesan SD, Mudliar S, Kaur S, et al. (2009) Bio-sequestration of carbon dioxide using carbonic anhydrase enzyme purified from Citrobacter freundii. World J Microbiol Biotechnol 25: 981-987.
31. Chang X, Zheng Y, Yang Q, Wang L, Pan J, et al. (2012) Carbonic anhydrase I is involved in the process of bone formation and is susceptible to ankylosing spondylitis. Arthritis Res Ther 14: R176.
32. Blanchong CA, Chung EK, Rupert KL, Yang Y, Yang Z, et al. (2001) Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol 1: 365-392.
33. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, et al. (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9: 721-731.
34. Chen Z, Koralov SB, Kelsoe G, (2000) Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 192: 1339-1352.
35. Marijon E, Mirabel M, Celermajer DS, Jouven X, (2012) Rheumatic heart disease. Lancet 379: 953-964.
36. Hartung K, Baur MP, Coldewey R, Fricke M, Kalden JR, et al. (1992) Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 90: 1346-1351.
37. Man XY, Luo HR, Li XP, Yao YG, Mao CZ, et al. (2003) Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese. Ann Rheum Dis 62: 71-73.
38. Scully LJ, Toze C, Sengar DP, Goldstein R, (1993) Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology 104: 1478-1484.
39. Messias IJ, Cavalcanti E, Radominski SC, (1995) Increased frequency of the C4A*6 rare allele in rheumatic heart disease. Scand J Rheumatol 24: 164-168.
40. Baker C, Belbin O, Kalsheker N, Morgan K, (2007) SERPINA3 (aka alpha-1-antichymotrypsin). Front Biosci 12: 2821-2835.
41. Chopra P, Wanniang J, Sampath KA, (1992) Immunohistochemical and histochemical profile of Aschoff bodies in rheumatic carditis in excised left atrial appendages: an immunoperoxidase study in fresh and paraffin-embedded tissue. Int J Cardiol 34: 199-207.
42. Aguilera O, Quiros LM, Fierro JF, (2003) Transferrins selectively cause ion efflux through bacterial and artificial membranes. FEBS Lett 548: 5-10.
43. Otto BR, Verweij-van VAM, MacLaren DM, (1992) Transferrins and heme-compounds as iron sources for pathogenic bacteria. Crit Rev Microbiol 18: 217-233.
44. Legrand D, Mazurier J, Montreuil J, Spik G, (1988) Structure and spatial conformation of the iron-binding sites of transferrins. Biochimie 70: 1185-1195.
45. Andres MT, Fierro JF, (2010) Antimicrobial mechanism of action of transferrins: selective inhibition of H+-ATPase. Antimicrob Agents Chemother 54: 4335-4342.
46. Kyriakides TR, Bornstein P, (2003) Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost 90: 986-992.
47. Chapman HA, (1997) Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9: 714-724.
48. Akhtar S, Meek KM, James V, (1999) Immunolocalization of elastin, collagen type I and type III, fibronectin, and vitronectin in extracellular matrix components of normal and myxomatous mitral heart valve chordae tendineae. Cardiovasc Pathol 8: 203-211.
49. Bouchey D, Argraves WS, Little CD, (1996) Fibulin-1, vitronectin, and fibronectin expression during avian cardiac valve and septa development. Anat Rec 244: 540-551.